FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

類似資料

• Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer
  著者:: Macbeth, F, 等
  出版事項: (2009)
• FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in^®<b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer
  著者:: Macbeth Fergus R, 等
  出版事項: (2009-10-01)
• Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
  著者:: Dong Qian, 等
  出版事項: (2015-01-01)
• Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
  著者:: Crosby, T, 等
  出版事項: (2017)
• Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial
  著者:: Sadhna Kannan, 等
  出版事項: (2021-03-01)